Head to head
Eldorado Gold vs Newmont
Side-by-side on the measures that matter, with a plain-English read. Full detail: EGO · NEM
EGO
Eldorado Gold
24.75-7.79%
1-year price shape — -7% over the period
Quant Rating D · 33/100
vs
NEM
Newmont
94.68-5.37%
1-year price shape — +17% over the period
Quant Rating D · 58/100
1-year performance, rebased to 100
Newmont edges it on the scoreable measures. Newmont has the highest Quant Rating (58); Newmont has done best over the past year (+17%); Newmont pays the highest dividend yield.
| EGO | NEM | |
|---|---|---|
| Snapshot | ||
| Sector | Gold | Gold |
| Last price | 24.75 | 94.68 |
| Change today | -7.79% | -5.37% |
| 1-year return | -7.2% | +16.5% |
| Market cap | $6.46B | $98.39B |
| 52-week range | 24.63 – 50.59 | 82.34 – 135.01 |
| Valuation | ||
| P/E (TTM) | 8.36 | 10.98 |
| P/E percentile, own 5-yr range | 37th | 50th |
| P/B | 0.93 | 2.76 |
| Dividend yield | 0.91% | 1.09% |
| Profitability & growth | ||
| EPS (TTM) | 2.47 | 6.39 |
| Net profit (TTM) | $644.82M | $6.64B |
| Revenue (TTM) | $2.09B | $26.61B |
| Provider revenue period date | 2026-09-29 | 2026-09-29 |
| Revenue growth (YoY) | +17.7% | +15.2% |
| Gross margin | 51.6% | 59.7% |
| Operating margin | 44.6% | 55.6% |
| Net margin | 31.9% | 34.7% |
| Free cash flow (TTM) | $-824.80M | $10.07B |
| Provider cash-flow period date | 2026-09-29 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 80.3% | 82.2% |
| Insider activity (12mo) | 19 buy / 14 sell | 20 buy / 27 sell |
| Short interest (% of float) | 5.8% | 1.7% |
| Analyst consensus | 67% buy / 33% hold (9) | 93% buy / 7% hold (14) |
| Analyst price target | $46 (+86%) | $139 (+47%) |
| StockVane view | ||
| StockVane Quant Rating | D (33) | D (58) |
| Company | ||
| Employees | 8,006 | 44,100 |
| Founded | 1992 | 1921 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.